Ferguson, Sherise D. http://orcid.org/0000-0002-6344-0615
Bindal, Shivani
Bassett, Roland L. Jr.
Haydu, Lauren E.
McCutcheon, Ian E.
Heimberger, Amy B.
Li, Jing
O’Brien, Barbara J.
Guha-Thakurta, Nandita
Tetzlaff, Michael T.
Tawbi, Hussein
Davies, Michael A.
Glitza, Isabella C.
Funding for this research was provided by:
AIM at Melanoma (n/a)
University of Texas MD Anderson Cancer Center (n/a)
Miriam and Sheldon G. Adelson Medical Research Foundation (n/a)
Article History
Received: 24 October 2018
Accepted: 4 February 2019
First Online: 7 March 2019
Compliance with ethical standards
:
: Dr. Davies has served on the advisory boards for BMS, Norvartis, Roche/Genetech, GSK, Sanofi-Aventis, Vaccinex and Syndax and has been the PI of institution grants from BMS, Astrzeneca, GSK, Roche/Genetech, Myriad and Oncothyreon. Dr. Tetzlaff has advisory board relationships with Novartis, Myriad and Seattle Genetics.
: This article does not contain any studies with human participants or animals performed by any of the authors.